Clinical Scorecard: Assessing the Clinical Significance of Metagenomic Next-Generation Sequencing for CNS Infections: A Study on Diagnostic Pathways and Resource Allocation

At a Glance

Key Highlights

• Traditional diagnostic methods for CNS infections have limited sensitivity, narrow pathogen targets, and delayed results.
• mNGS can reduce the number of microbiological tests, lumbar punctures, and time to diagnosis significantly in infectious and autoimmune CNS diseases.
• Bayesian modeling suggests mNGS (e.g., Delve Detect) could streamline diagnostic workflows by detecting both RNA and DNA pathogens within ~48 hours.

Guideline-Based Recommendations

Diagnosis

• Consider mNGS testing in patients with suspected CNS infections or autoimmune encephalitis when traditional diagnostics are inconclusive after 48 hours.
• Use mNGS to detect a broad range of pathogens including DNA viruses, RNA viruses, bacteria, fungi, and parasites directly from CSF.

Management

• Incorporate mNGS results to guide targeted antimicrobial or immunomodulatory therapies, potentially reducing empiric broad-spectrum treatments.
• Utilize mNGS to potentially avoid unnecessary lumbar punctures and extensive microbiological testing.

Monitoring & Follow-up

• Monitor turnaround times and diagnostic yield of mNGS to optimize clinical decision-making and resource allocation.
• Track clinical outcomes to assess impact of mNGS-guided diagnosis on treatment efficacy and hospital length of stay.

Risks

• Be aware of high cost and variable test performance of mNGS platforms.
• Interpret mNGS results in clinical context to avoid misdiagnosis due to contamination or incidental findings.

Patient & Prescribing Data

Patients hospitalized with confirmed CNS infections or autoimmune encephalitis undergoing diagnostic evaluation

Use of mNGS could reduce empiric broad-spectrum antimicrobial use by enabling earlier targeted therapy and decrease the number of drugs prescribed during hospitalization.

Clinical Best Practices

• Apply mNGS testing early in diagnostic algorithms for patients with suspected CNS infections when rapid diagnosis is not achieved by standard methods.
• Use Bayesian modeling to interpret mNGS test results considering pretest probabilities based on clinical and epidemiological data.
• Integrate mNGS findings with traditional microbiological and clinical data to confirm diagnosis and guide treatment decisions.
• Limit repeat lumbar punctures and extensive microbiological testing when mNGS provides definitive pathogen identification.
• Ensure institutional protocols address cost, turnaround time, and clinical interpretation of mNGS to maximize utility.

References

• Columbia University Irving Medical Center IRB Protocol AAAR3440
• Delve Detect mNGS platform information